MEXICO CITY, June 2, 2023 /PRNewswire/ — Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a … Read more
TAMPA, Fla., June 2, 2023 /PRNewswire/ — The National Pediatric Cancer Foundation (NPCF) partnered with First Watch to provide a dream opportunity for Sophia, a ten-year-old cancer warrior who wants to be a Chef when she grows up! Sophia & Chef Shane at First Watch Sophia visited a local First Watch location where she joined … Read more
Guyton’s song “How You Love Someone” to raise Alzheimer’s awareness and encourage more conversations during Alzheimer’s and Brain Awareness Month CHICAGO, June 2, 2023 /PRNewswire/ — The Alzheimer’s Association has joined forces with four-time GRAMMY-nominated country artist Mickey Guyton to raise awareness for Alzheimer’s disease during Alzheimer’s and Brain Awareness Month. Music Moments — a … Read more
Customized high-protein, high-fiber, low-calorie smoothie mix to deliver every vitamin, mineral and antioxidant your body needs. COLUMBUS, Ohio, June 2, 2023 /PRNewswire/ — Goode Health is thrilled to announce the launch of its Ultimate Wellness Blend, a customizable smoothie blend packed with four kinds of high-grade plant-based protein, plus a prebiotic fiber, a unique mix … Read more
Six médicaments développés par Dragonfly sont actuellement en clinique. WALTHAM, Massachusetts, 2 juin 2023 /PRNewswire/ — Dragonfly Therapeutics, Inc., a annoncé aujourd’hui avoir élargi son équipe de direction clinique en y intégrant le Dr Robin Edwards, anciennement directeur mondial des sciences translationnelles chez Daiichi Sankyo et directeur des sciences translationnelles chez Bristol Myers Squibb, et … Read more
Leading academic cancer research network led by Aster Insights accelerates oncology discovery and therapeutic development TAMPA, Fla. and KANSAS CITY, Kan., June 2, 2023 /PRNewswire/ — Aster Insights, the leading provider of technology-enabled data and analytics solutions for oncology discovery, today announced The University of Kansas Cancer Center will join its Oncology Research Information Exchange Network … Read more
Kisqali is the first and only CDK4/6 inhibitor to demonstrate a consistent, clinically meaningful benefit across a broad population of patients with HR+/HER2- early breast cancer, regardless of disease stage, menopausal or nodal status1 Results were also consistent across all secondary endpoints, including distant disease-free survival and recurrence-free survival, with a trend for improved overall … Read more
Stephen P. MacMillan, Hologic CEO, named non-executive Chair of Illumina’s Board Scott B. Ullem, CFO of Edwards Lifesciences, also named to Board SAN DIEGO, June 2, 2023 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of governance changes consistent with the goal of enhancing long-term … Read more
Mitra® et hemaPEN® reçoivent la certification réglementaire en tant que dispositifs médicaux pour le prélèvement d’échantillons sanguins à distance dans les soins de santé, les essais cliniques et les programmes de surveillance à domicile en Europe et au Royaume-Uni. MELBOURNE, Australie, 2 juin 2023 /PRNewswire/ — Trajan Scientific and Medical, l’un des principaux fournisseurs de … Read more
IRVINE, Calif., June 2, 2023 /PRNewswire/ — HeyGears, a leading provider of 3D printing technology and solutions, has announced the global launch of pre-sales for its first desktop 3D printing solution available for consumers, the UltraCraft Reflex. The pre-sale begins June 1st via the HeyGears’ official online store. Heygears_Image The UltraCraft Reflex is an all-in-one production platform enabling … Read more